Reciprocal Innovation – Good short-term outcomes despite extensive pre-3rd line HIV drug resistance in Kenya2020-08-12T13:16:07-04:00

Good short-term outcomes despite extensive pre-3rd line HIV drug resistance in Kenya

Principal Investigator Dr. Suzanne Goodrich
International Collaborator(s)
Project Title Good short-term outcomes despite extensive pre-3rd line HIV drug resistance in Kenya
Priority Area Improving the quality of care
The Intervention This should be adapted to a US context as the burden of HIV drug resistance is growing and peers could play a vital role in addressing the side effect concerns and psychosocial concerns US patients have.
Key Facilitators Since AMPATH’s North America faculty also work in the main outpatient HIV clinic, it would be fairly straightforward to try to replicate this program in Indianapolis once the regulatory issues are sorted out and peer based healthcare workers are recognized as allowable providers. These issues have already been addressed by our other colleagues working in other domains such as maternal and child health.
Target Population This strategy has typically been utilized with populations that are at risk or vulnerable. This includes lower socioeconomic status, low-literacy populations, and HIV patients at risk for treatment failure or loss to followup. US based experiences have typically focused on similar populations
Process to Implementation n/a
Key Stakeholders n/a
Scaled or Transferred? n/a
Type of Research n/a
Published Materials n/a but we have a published abstract from IAS highlighting the improved HIV outcomes of patients receiving care through this model
Year Funded

Get Involved with Indiana CTSI